Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2025 dividend on the ...

In today’s CEO Daily: Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2025 dividend on the company’s common stock, payable June 13 ...

A new film features leading business figures discussing how New York's Commercial Division boosts economic growth and ...

Local drugmakers donated $4 million to President Donald Trump’s inauguration committee earlier this year as the administration contemplates tariffs that could impose major financial strain on the ...

“She’s an example of this emerging face of cancer that's really quite challenging and quite alarming,” Deignan said.

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

Pfizer Inc. (PFE) is a multinational pharmaceutical and biotechnology company headquartered in New York. It researches, develops, and manufactures biopharmaceutical products for use in the ...

Nina Trentmann is the former bureau chief for The Wall Street Journal’s CFO Journal. Based in New York, Nina managed the ...